Table 3. The area under the ROC curve analysis of the sLC ratio single indicator and combined with other indicators.
Clinical indicators | AUC | Standard error | 95% confidence interval (AUC) | Sensitivity (%) | Specificity (%) | P 1 | P 2 |
---|---|---|---|---|---|---|---|
sLC ratio | 0.875 | 0.034 | 0.832~0.910 | 81.16 | 84.87 | <0.0001* | |
sLC ratio+β 2 -MG | 0.949 | 0.016 | 0.918~0.871 | 92.75 | 86.75 | <0.0001* | 0.0054* |
sLC ratio+LDH | 0.889 | 0.030 | 0.848~0.922 | 81.16 | 93.59 | <0.0001* | 0.2978 |
sLC ratio+Ig | 0.870 | 0.035 | 0.827~0.906 | 81.16 | 94.44 | <0.0001* | 0.2305 |
sLC ratio+β 2 -MG+LDH | 0.950 | 0.161 | 0.918~0.971 | 94.20 | 85.47 | <0.0001* | 0.0056* |
sLC ratio+β 2 -MG+Ig | 0.952 | 0.015 | 0.922~0.973 | 94.20 | 86.75 | <0.0001* | 0.004* |
sLC ratio+LDH+Ig | 0.887 | 0.031 | 0.846~0.920 | 81.16 | 93.59 | <0.0001* | 0.3646 |
sLC ratio+β 2 -MG+LDH+Ig | 0.952 | 0.015 | 0.922~0.973 | 94.20 | 85.47 | <0.0001* | 0.0043* |
* represents P<0.05, the difference is statistically significant. P1 is the statistical significance of the area under the ROC curve of each indicator. P2 is the statistical significance of the difference between sLC ratio and combined indicators in the context of the area under the ROC curve.